What is Insulet's cash received from option exercises?

Insulet (PODD) reported cash received from option exercises of $400K in Q1 2026.

How has Insulet's cash received from option exercises changed year-over-year?

Insulet's cash received from option exercises decreased by 84.0% year-over-year, from $2.5M to $400K.

What is the long-term trend for Insulet's cash received from option exercises?

Over 4 years (2021 to 2025), Insulet's cash received from option exercises has grown at a 5.4% compound annual growth rate (CAGR), from $15.4M to $19M.

Insulet PODD Cash received from option exercises

Cash received from option exercises at other companies

West Pharmaceutical ServicesWST

——

Other financials

Income statement

See full

Revenue$761.7M+33.9%

Gross profit$529.0M+29.3%

Operating income$122.1M+37.5%

Net income$91.1M+157%

EPS (diluted)$1.30+160%

Balance sheet

See full

Cash & equivalents$480.4M-62.6%

Total debt$969.7M-45.5%

Total equity$1.3B-2.1%

Total assets$3.0B-15.1%

Cash flow

See full

Operating cash flow$113.8M+78.4%

CapEx$24.3M+97.6%

Free cash flow$89.5M+73.8%

Valuation

See full

Market cap$10.1B-19.9%

Enterprise value$10.59B-19.4%

P/E33.3×+2.0×

P/S3.5×-2.3×

Profitability

See full

Gross margin71%+0.6pp

Operating margin17.5%+2.0pp

Net margin10.4%-7.9pp

FCF margin14.3%+1.1pp

Returns & leverage

See full

Return on equity23%-14.9pp

Debt / equity0.7×-0.6×

Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's cash received from option exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insulet's cash received from option exercises?: Insulet (PODD) reported cash received from option exercises of $400K in Q1 2026.
How has Insulet's cash received from option exercises changed year-over-year?: Insulet's cash received from option exercises decreased by 84.0% year-over-year, from $2.5M to $400K.
What is the long-term trend for Insulet's cash received from option exercises?: Over 4 years (2021 to 2025), Insulet's cash received from option exercises has grown at a 5.4% compound annual growth rate (CAGR), from $15.4M to $19M.